New immunostimulant targets BRD

New immunostimulant targets BRD

BAYER HealthCare LLC Animal Health recently introduced DNA Immunostimulant Zelnate, a new innovation for the cattle industry that aids in the treatment of bovine respiratory disease (BRD) due to Mannheimia haemolytica.

This is the first immunostimulant that effectively reduces mortality and lung lesions by enhancing the animal's own immune system to help fight this infectious disease, potentially reducing the need for antibiotics, Bayer sai

All access premium subscription

This content requires a subscription to Feedstuffs in order to access. If you are a paid subscriber, use your email and password to Log In now.


Current Feedstuffs Subscribers: Online and mobile access are now included at no charge to you. To read this article, use your subscriber email and password to log-in to your account (or contact us for assistance in updating your account.)


Not Currently a Subscriber: Subscribe NOW to Feedstuffs and receive our print and/or digital publications, enewsletters and premium online content. Visit Feedstuffs.com and click on Subscribe at the top of the page for more information.


SUBSCRIBE NOW https://circulation.feedstuffs.com/Publications.aspx


TO RENEW YOUR SUBSCRIPTION https://circulation.feedstuffs.com/SubscriptionOffers.aspx


Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish